These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 17654685

  • 1. Hemochromatosis-associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblasts.
    Nearman ZP, Szpurka H, Serio B, Warshawksy I, Theil K, Lichtin A, Sekeres MA, Maciejewski JP.
    Am J Hematol; 2007 Dec; 82(12):1076-9. PubMed ID: 17654685
    [Abstract] [Full Text] [Related]

  • 2. [Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia].
    Nie L, Ai XF, Zheng YZ, Li QH, Yang L, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):223-8. PubMed ID: 19731820
    [Abstract] [Full Text] [Related]

  • 3. High incidence of hemochromatosis gene mutations in the myelodysplastic syndrome: the Budapest Study on 50 patients.
    Várkonyi J, Tarkovács G, Karádi I, Andrikovics H, Varga F, Varga F, Demeter J, Tordai A.
    Acta Haematol; 2003 Apr; 109(2):64-7. PubMed ID: 12624489
    [Abstract] [Full Text] [Related]

  • 4. Haemochromatosis gene mutations in a clustered Italian population: evidence of high prevalence in people of Celtic ancestry.
    Pozzato G, Zorat F, Nascimben F, Gregorutti M, Comar C, Baracetti S, Vatta S, Bevilacqua E, Belgrano A, Crovella S, Amoroso A.
    Eur J Hum Genet; 2001 Jun; 9(6):445-51. PubMed ID: 11436126
    [Abstract] [Full Text] [Related]

  • 5. Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes.
    Wulfert M, Küpper AC, Tapprich C, Bottomley SS, Bowen D, Germing U, Haas R, Gattermann N.
    Exp Hematol; 2008 May; 36(5):577-86. PubMed ID: 18439489
    [Abstract] [Full Text] [Related]

  • 6. JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
    Schmitt-Graeff AH, Teo SS, Olschewski M, Schaub F, Haxelmans S, Kirn A, Reinecke P, Germing U, Skoda RC.
    Haematologica; 2008 Jan; 93(1):34-40. PubMed ID: 18166783
    [Abstract] [Full Text] [Related]

  • 7. Nucleolar abnormalities--a defect of the nucleolar preribosome assembly--in ringed sideroblasts in refractory anaemia with ringed sideroblasts (RARS) of myelodysplastic syndrome (MDS). An electron microscopic study.
    Smetana K, Cermák J, Jirásková I, Malasková V.
    Sb Lek; 2003 Jan; 104(2):199-207. PubMed ID: 14577129
    [Abstract] [Full Text] [Related]

  • 8. HFE genotype and iron metabolism in Chinese patients with myelodysplastic syndromes and aplastic anemia.
    Nie L, Li L, Yang L, Zhang Y, Xiao Z.
    Ann Hematol; 2010 Dec; 89(12):1249-53. PubMed ID: 20563578
    [Abstract] [Full Text] [Related]

  • 9. Population-based study of the relationship between mutations in the hemochromatosis (HFE) gene and arthritis.
    Sherrington CA, Knuiman MW, Divitini ML, Bartholomew HC, Cullen DJ, Olynyk JK.
    J Gastroenterol Hepatol; 2006 Mar; 21(3):595-8. PubMed ID: 16638105
    [Abstract] [Full Text] [Related]

  • 10. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
    Papageorgiou SG, Pappa V, Papageorgiou E, Tsirigotis P, Kontsioti F, Panani A, Dervenoulas J, Economopoulos T.
    Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874
    [Abstract] [Full Text] [Related]

  • 11. Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance.
    Passam FH, Tsirakis G, Boula A, Fragou A, Consolas I, Alegakis A, Kyriakou DS, Alexandrakis MG.
    Clin Lab Haematol; 2004 Dec; 26(6):391-5. PubMed ID: 15595996
    [Abstract] [Full Text] [Related]

  • 12. Neutrophil-specific reduction in the expression of granulocyte--macrophage colony-stimulating factor receptor subunits in myelodysplastic syndromes.
    Shikama Y, Shichishima T, Ohto H, Jubinsky PT, Maruyama Y.
    Br J Haematol; 2000 Dec; 111(3):863-72. PubMed ID: 11122148
    [Abstract] [Full Text] [Related]

  • 13. Hemochromatosis-causing mutations C282Y and H63D are not risk factors for atherothrombotic cerebral infarction.
    Hruskovicová H, Milanez T, Kobal J, Potisk KP, Petrovic D, Peterlin B.
    Med Sci Monit; 2005 Jul; 11(7):BR248-52. PubMed ID: 15990686
    [Abstract] [Full Text] [Related]

  • 14. H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?
    de Diego C, Opazo S, Murga MJ, Martínez-Castro P.
    Eur J Haematol; 2007 Jan; 78(1):66-71. PubMed ID: 17042772
    [Abstract] [Full Text] [Related]

  • 15. Detection of CD55- and CD59-deficient granulocytic populations in patients with myelodysplastic syndrome.
    Kaiafa G, Papadopoulos A, Ntaios G, Saouli Z, Savopoulos C, Tsesmeli N, Kontoninas Z, Chatzinikolaou A, Tsavdaridou V, Klonizakis I, Hatzitolios A.
    Ann Hematol; 2008 Apr; 87(4):257-62. PubMed ID: 18158579
    [Abstract] [Full Text] [Related]

  • 16. Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome.
    Cuijpers ML, Raymakers RA, Mackenzie MA, de Witte TJ, Swinkels DW.
    Br J Haematol; 2010 May; 149(3):322-33. PubMed ID: 20067561
    [Abstract] [Full Text] [Related]

  • 17. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
    Yao DM, Qian J, Xu WR, Lin J, Jiang YW, Fei X, Han LX, Wang Y, Cen JN, Chen ZX.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
    [Abstract] [Full Text] [Related]

  • 18. Occurrence of the JAK2 V617F mutation in the WHO provisional entity: myelodysplastic/myeloproliferative disease, unclassifiable-refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
    Remacha AF, Nomdedéu JF, Puget G, Estivill C, Sarda MP, Canals C, Aventin A.
    Haematologica; 2006 May; 91(5):719-20. PubMed ID: 16670082
    [Abstract] [Full Text] [Related]

  • 19. HFE gene mutation and oxidative damage biomarkers in patients with myelodysplastic syndromes and its relation to transfusional iron overload: an observational cross-sectional study.
    De Souza GF, Ribeiro HL, De Sousa JC, Heredia FF, De Freitas RM, Martins MR, Gonçalves RP, Pinheiro RF, Magalhães SM.
    BMJ Open; 2015 Apr 03; 5(4):e006048. PubMed ID: 25841232
    [Abstract] [Full Text] [Related]

  • 20. Hemochromatosis gene mutations, liver function tests and iron status in alcohol-dependent patients admitted for detoxification.
    Robinson G, Narasimhan S, Weatherall M, Beasley R.
    J Gastroenterol Hepatol; 2007 Jun 03; 22(6):852-4. PubMed ID: 17565641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.